Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antidiabetic Drugs”

243 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 243 results

Post-approval studies (Phase 4)Study completedNCT01698931
What this trial is testing

Efficacy of Repaglinide in Subjects With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 9
Large-scale testing (Phase 3)Study completedNCT03798054
What this trial is testing

Evaluation of Insulin Glargine/Lixisenatide Fixed Ratio Combination in Patients With Type 2 Diabetes Insufficiently Controlled With Oral Antidiabetic Drug(s)

Who this might be right for
Type 2 Diabetes Mellitus
Sanofi 878
Testing effectiveness (Phase 2)UnknownNCT01413035
What this trial is testing

Safety and Efficacy Study of Umbilical Cord/Placenta-Derived Mesenchymal Stem Cells to Treat Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Shandong University 30
Large-scale testing (Phase 3)Study completedNCT07058545
What this trial is testing

CJC-1134-PC Injection in Antidiabetic Treatment-naive Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control

Who this might be right for
Type 2 Diabetes Mellitus - Poor Control
Changshan ConjuChem BioPharmaceutical Research and Development (Hebei) Co., Ltd. 474
Large-scale testing (Phase 3)Study completedNCT02752412
What this trial is testing

Efficacy and Safety of LixiLan Versus Insulin Glargine Alone Both With Metformin in Japanese With Type 2 Diabetes Mellitus Inadequately Controlled on Basal Insulin and Oral Antidiabetic Drugs

Who this might be right for
Type 2 Diabetes Mellitus
Sanofi 513
Post-approval studies (Phase 4)Study completedNCT00807092
What this trial is testing

Comparing the Efficacy and Safety of Biphasic Insulin Aspart 30 and Biphasic Human Insulin 30 on Blood Sugar Control in Subjects With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 145
Large-scale testing (Phase 3)Study completedNCT00246623
What this trial is testing

US Inhaled Insulin Dose Titration Study

Who this might be right for
Diabetes Mellitus, Type 2
Pfizer 120
Post-approval studies (Phase 4)UnknownNCT02091336
What this trial is testing

Oral Antidiabetic Agents in Pregnancy

Who this might be right for
Gestational Diabetes
Hospital de Clinicas de Porto Alegre 80
Large-scale testing (Phase 3)Study completedNCT01937598
What this trial is testing

Antidiabetic Effects of Adding a DPP-4 Inhibitor to Pre-Existing Treatment With an Incretin Mimetic in Patients With T2D

Who this might be right for
Type 2 Diabetes
Michael A. Nauck 16
Not applicableStudy completedNCT00865397
What this trial is testing

Observational Study in Type 2 Diabetics Failing on Oral Antidiabetic Therapy and Starting on Insulin Treatment

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 1,032
Large-scale testing (Phase 3)Study completedNCT01616784
What this trial is testing

The REPOSE (Relative Effectiveness of Pumps Over MDI and Structured Education) Trial

Who this might be right for
Type 1 Diabetes
Sheffield Teaching Hospitals NHS Foundation Trust 267
Post-approval studies (Phase 4)Study completedNCT01618214
What this trial is testing

Comparison of Subject-driven Titration of Biphasic Insulin Aspart (BIAsp) 30 Twice Daily Versus Investigator-driven Titration of BIAsp 30 Twice Daily Both in Combination With Oral Antidiabetic Drugs in Subjects With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 344
Not applicableUnknownNCT01101204
What this trial is testing

The Effects of Hypolipemic and Antidiabetic Treatment on Cytokines

Who this might be right for
DiabetesDyslipidemiaInflammation+1 more
Medical University of Silesia 200
Not applicableStudy completedNCT02456428
What this trial is testing

Incretin-based Drugs and the Risk of Heart Failure

Who this might be right for
Type 2 Diabetes Mellitus
Canadian Network for Observational Drug Effect Studies, CNODES 1,499,650
Not applicableUnknownNCT04712409
What this trial is testing

Surgical Innovation for Diabetes Treatment 2

Who this might be right for
Enteroendocrine Physiological Changes in Superobese Patients Submitted to Two Different Bariatric ProceduresDetermine Whether BPD With DS or SADI-S as Primary or Revisional Surgery is Superior Than the Other as First Choice for the SuperobeseDetermine Whether or Not Revision Surgery is as Effective as Primary Surgery and Understand the Physiological Mechanisms Inherent in These Putative Differences
Hospital de Sao Sebastiao
Post-approval studies (Phase 4)Study completedNCT02738151
What this trial is testing

Efficacy and Safety of Toujeo® Versus Tresiba® in Insulin-Naive Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Oral Antihyperglycemic Drug(s) ± GLP-1 Receptor Agonist

Who this might be right for
Diabetes Mellitus, Type 2
Sanofi 929
Testing effectiveness (Phase 2)Study completedNCT00382239
What this trial is testing

Assess the Effect on Glucose Control and Safety and Tolerability of LY2148568 In Japanese Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 153
Post-approval studies (Phase 4)Study completedNCT03982238
What this trial is testing

Effects of Hypoglycemic Drugs on Testosterone Levels in Type 2 Diabetes Patients

Who this might be right for
Type 2 Diabetes
Majianhua 74
Not applicableActive Not RecruitingNCT06913101
What this trial is testing

Comparison of Once-Weekly Trelagliptin vs. Once-Daily Vildagliptin for HbA1c Reduction in Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
PNS Hafeez - Naval Hospital 102
Not applicableStudy completedNCT00842192
What this trial is testing

An Observational Study in Type 2 Diabetic Patients on Oral Antidiabetic Drugs and Basal Insulin in Near East Countries

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 2,155
Load More Results
40